Understanding resistance acquisition by Pseudomonas aeruginosa and possible pharmacological approaches in palliating

Mony Thakur1, Khushboo2, Yatin Kumar1

  • 1Department of Microbiology, Central University of Haryana, Mahendergarh, Haryana 123031, India.

PubMed

Insights

Pseudomonas aeruginosa infections are difficult to treat due to antibiotic resistance and biofilm formation. Targeting quorum sensing (QS) and biofilms with natural compounds offers a promising anti-virulence strategy.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Pseudomonas aeruginosa is a nosocomial pathogen causing severe infections, particularly in immunocompromised individuals.
  • It employs various virulence factors, including pyocyanin, proteases, and exotoxins, contributing to host invasion and persistence.
  • Antibiotic resistance and biofilm formation by P. aeruginosa present significant challenges in clinical settings, leading to chronic infections and increased mortality.

Purpose of the Study:

  • To review the mechanisms of antibiotic resistance in P. aeruginosa.
  • To explore alternative anti-virulence strategies, focusing on anti-biofilm and anti-quorum sensing (QS) approaches.
  • To highlight the potential of phytochemicals and essential oils in combating P. aeruginosa pathogenicity.

Main Methods:

  • Literature review of studies on P. aeruginosa virulence factors, antibiotic resistance, and biofilm formation.
  • Analysis of quorum sensing (QS) mechanisms, particularly the role of the LasR regulatory protein.
  • Evaluation of pharmacological approaches, including natural compounds, for anti-biofilm and anti-QS activity.

Main Results:

  • P. aeruginosa utilizes multiple virulence factors and exhibits resistance to conventional antibiotics.
  • Biofilm formation is a critical factor in chronic infections and treatment failure.
  • Inhibition of QS and biofilm formation via natural products like phytochemicals and essential oils shows promise in laboratory settings.

Conclusions:

  • Developing strategies to disrupt P. aeruginosa biofilms and overcome antibiotic resistance is crucial.
  • Anti-virulence approaches targeting QS and biofilm formation represent a viable alternative to traditional antibiotics.
  • Targeting the LasR protein with antagonist molecules is a potential therapeutic avenue for P. aeruginosa infections.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
40
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
42
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359